Analyzing infant cry acoustics for advanced analysis and insight.

PedialyDx is developing products to improve assessment and diagnosis of babies.

PedialyDx uses Machine Learning and advanced acoustic analysis techniques to quantify acoustics of baby cry.  The company was founded based on research at Brown University and Women & Infants Hospital, led by Dr. Barry Lester and Dr. Stephen Sheinkopf.

Learn More

PedialyDx uses Machine Learning and advanced acoustic analysis techniques to quantify acoustics of baby cry.  The company was founded based on research at Brown University and Women & Infants Hospital, led by Dr. Barry Lester and Dr. Stephen Sheinkopf.

PedialyDx is developing products to improve assessment and diagnosis of babies.

Breakthrough research in pediatric care.

Our team has decades of research, with dozens of publications, demonstrating that acoustic analysis of baby cries can be correlated to immediate and future developmental conditions of the baby.

Learn More

Our team has decades of research, with dozens of publications, demonstrating that acoustic analysis of baby cries can be correlated to immediate and future developmental conditions of the baby.

Breakthrough research in pediatric care.

A multidisciplinary team innovating solutions for the assessment and treatment of infants.

PedialyDx has assembled a team of world-class business development, software development, clinical and academic research experts, who are working together to bring novel products to market to improve assessment and treatment of babies.

Pete O'Neill
CEO
Brian Beckrest
VP Product Development
Dr. Barry Lester
Advisor
Dr. Stephen Sheinkopf
Advisor

PedialyDx News

PedialyDx has received a Notice Of Award for our Phase 2 SBIR

September 23, 2022

PedialyDx has received a notice of award for our phase 2 SBIR titled 'Diagnosis of Neonatal Opioid Withdrawal Syndrome (NOWS) and Development of a NOWS-App', which will support a 7-site study to increase our NOWS data and support development of NOWS-App product.

Learn More

Interested in learning more?

Get in touch with us to learn more about the work we are doing, inquire about upcoming studies, or discuss potential investment opportunities.